Tag: Africa

Posted on

Projet philanthropique de Deriv : Favoriser le changement social grâce au parrainage du 4L Trophy

En février de cette année, durant 10 jours s’est déroulé un rallye de 6 000 km au départ de la France pour le Maroc, dans le but d’aider les enfants défavorisés d’Afrique.

Course humanitaire de Deriv dans le désert marocain.

L’équipe parrainée par Deriv pendant le 4L Trophy.

PARIS, 22 juin 2023 (GLOBE NEWSWIRE) — Deriv, l’un des principaux brokers en ligne, a activement participé aux initiatives humanitaires en harmonie avec ses principales valeurs que sont la fiabilité, l’équité, la transparence et la responsabilité. Un peu plus tôt cette année, Deriv a parrainé une équipe de deux jeunes professionnels ayant remporté avec brio le 4L Trophy, une course de rallye humanitaire organisée annuellement pour collecter des fonds en faveur d’enfants défavorisés d’Afrique.

Le rallye 4L Trophy a démarré en France et s’est achevé au Maroc, couvrant ainsi une distance de 6 000 km pendant 10 jours. Les différents participants ont dû roulé sur des des terrains hostiles en franchissant divers points de contrôle. Un long trajet pour une noble cause, trajet tout au long duquel ont été distribués de la papeterie et des manuels scolaires à des enfants défavorisés.

Course humanitaire de Deriv dans le désert marocain.

« Rouler en terre inconnue, camper au milieu de nulle part pour franchir la ligne d’arrivée au final étaient à la fois passionnants et gratifiants », a affirmé Clement David, l’un des pilotes parrainés par Deriv. « Mais pouvoir par-dessus tout améliorer les vies d’enfants en leur apportant des fournitures scolaires indispensables a rendu l’expérience encore plus spéciale. »

Deriv soutient la course humanitaire au Maroc pendant le rallye 4L Trophy.

L’équipe parrainée par Deriv interagit avec des enfants marocains défavorisés pendant la course du 4L Trophy.

Pour Jean-Yves Sireau, fondateur et PDG de Deriv : « En participant au rallye 4L Trophy, Deriv affirme notre engagement à influencer positivement les communautés que nous servons. Nous croyons qu’il est important de soutenir les initiatives qui permettent aux individus et aux communautés de s’épanouir, ce qui passe essentiellement par l’éducation. »

« Nous pensons également que les entreprises ont une responsabilité envers la société » a ajouté Sireau. « Nos efforts philanthropiques visent à pousser d’autres organisations à apporter leur pierre à l’édifice pour rendre le monde meilleur. »

Deriv soutient la course humanitaire au Maroc pendant le rallye 4L Trophy.

Le rallye 4L Trophy n’est qu’un exemple parmi d’autres de l’engagement de Deriv dans les causes humanitaires. Au début de cette année, Deriv a également fait don de 11 boîtes de vêtements à la Fundacion Unidos por Cristo à Asuncion au Paraguay, un foyer résidentiel fournissant des soins complets à des enfants et adolescents à risque.

Pour en savoir plus sur Deriv et ses initiatives humanitaires, suivez-nous sur Derivlife et sur le compte Instagram de l’entreprise.

À propos de Deriv

Deriv a commencé son périple en 1999. Depuis lors, sa mission a consisté à rendre le trading en ligne accessible à tous et partout. Les produits de Deriv comprennent des plateformes de trading intuitives, plus de 200 actifs à trader (sur des marchés comme celui des devises, des actions et des crypto-monnaies), des types de transactions uniques, etc. Deriv s’engage envers les communautés en hissant ses initiatives humanitaires à de nouveaux standards dans l’ensemble de son réseau constitué de 20 bureaux répartis dans 16 pays.

CONTACT PRESSE
Aleksandra Zuzic
aleksandra@deriv.com

Des photos accompagnant ce communiqué sont disponibles aux adresses suivantes :
https://www.globenewswire.com/NewsRoom/AttachmentNg/84da82a4-68fe-4100-b936-f179348cbb9e/fr
https://www.globenewswire.com/NewsRoom/AttachmentNg/61b1b768-e495-4845-aaaa-b96adda137a6/fr

GlobeNewswire Distribution ID 1000826503

Posted on

SAP Fioneer launches tailored SME banking offering

WALLDORF, Germany, June 22, 2023 (GLOBE NEWSWIRE) — SAP Fioneer, a leading global provider of financial services software solutions and platforms, has announced the launch of its Fioneer SME Banking Edition. The solution will enable banks and neobanks to offer banking capabilities in a digital-first and data-driven approach, tailored to the financial needs of small and medium-sized enterprises (SMEs) – a historically underserved market segment.

The SME sector is a vital component of the global economy, accounting for 99% of UK and EU businesses and employing approximately 16.4 million and 84 million people respectively.* Despite making up a significant proportion of GDP and the workforce, SMEs have traditionally struggled to access financial services that meet their unique needs, as the perceived risks and costs associated are deemed too high.

Fioneer SME Banking Edition addresses these challenges by connecting banks to external data sources such as Open Banking, central company registry, e-commerce and Enterprise Resource Planning (ERP) data, to form actionable insights that significantly help SMEs to stay ahead. This will give SMEs clear transparency about cashflow and provide insight to the banks and enable e.g. smart funding options, offering more variety and increasing the number of businesses banks can serve.

As a unique end-to-end solution, Fioneer SME Banking Edition covers front-to-back capabilities and seamlessly integrates with any core banking system. It enables banks to offer services that go beyond traditional banking products such as loans and deposits. Banks will be able to broaden their offering with embedded services and stronger financial advice directly for SMEs. The solution can also be easily integrated and connect to ecosystems via pre-configured APIs.

Charlie Platt, Managing Director of Banking at SAP Fioneer, comments on the launch: “SMEs represent the lifeblood of the economy, and it is critical that they are able to access the financial services they deserve. Through our SME Banking Edition, banks will be able to create commercially viable, unique and better banking experiences for SMEs that will help them to stay ahead in a challenging economic environment.”

“The introduction of our Fioneer SME Banking Edition significantly strengthens how banks interact with SMEs. Utilizing our proven technology, we’re facilitating banks to better serve SMEs in a dynamic economic landscape. Drawing inspiration from the B2C market, we’re empowering banks to elevate their service offerings for SMEs,” adds Dirk Kruse, CEO of SAP Fioneer.

*Business population estimates for the UK and regions 2022 (UK Government), Statista 2022

About SAP Fioneer

SAP Fioneer was launched in 2021 as a joint venture between global technology leader SAP and entrepreneurial investor Dediq to become the world’s leading provider of financial services software solutions and platforms.  With a broad ecosystem of partners, over 800 financial services customers and more than 1,000 employees, SAP Fioneer is a global business present in 17 countries across Europe, North and Latin America, Middle East and Asia-Pacific.

By combining the speed and agility of a start-up with the proven capabilities of a best-in-class software company, SAP Fioneer enables banks, insurance companies and challengers to run, transform and grow while meeting their need for speed, scalability, and cost-efficiency through digital business innovation, cloud technology, and solutions that cover banking and insurance processes end-to-end.

For more information, visit www.sapfioneer.com. Follow SAP Fioneer on Twitter and on LinkedIn.

Press enquiries:
press@sapfioneer.com

GlobeNewswire Distribution ID 1000826504

Posted on

Zoom Scheduler, now generally available, allows users to align calendars with clients and contacts quickly and easily

Zoom extends free signup period for Zoom Scheduler to July 20

SAN JOSE, Calif., June 21, 2023 (GLOBE NEWSWIRE) — Today, Zoom announced general availability for its new Zoom Scheduler tool and the extension of the free signup period. Zoom Scheduler makes finding the perfect meeting time easier by sharing availability for others to conveniently book appointments.

“We heard again and again from our customers that they were looking for a convenient way to book appointments without leaving the Zoom platform,” said Joseph Chong, Head of Product, Solutions, and Industry Marketing, Zoom. “With Zoom Scheduler, they can. Based on positive feedback, we will be offering Zoom Scheduler for free for anyone to try for one more month.”

Zoom is known for simplifying collaboration tools, and its latest product has taken on everyone’s least favorite meeting task: aligning calendars. Sharing availability windows back and forth manually takes up valuable time and adds more friction to a workday. Meeting with potential customers or clients often compounds this problem, as external participants lack visibility into one another’s calendars. Zoom Scheduler allows hosts to generate windows of availability that others can use to book appointments. With Zoom Scheduler, users will be able to grow their businesses faster and get more done so they can spend more time on what matters: preparing for the meeting or taking a break.

Get together with Zoom Scheduler

Now generally available, Zoom Scheduler places a meeting on the host’s calendar with a Zoom Meetings link already included, saving both participants time. Hosts can use their preferred calendar: Zoom Scheduler works seamlessly with Zoom Meetings and Zoom Mail and Calendar and integrates with both Google Calendar and Microsoft 365.

Features of Zoom Scheduler include:

  • Ability to schedule one-on-one meetings or one-to-many group meetings and specify how many people can attend any available slot.
  • Choose recurring availability or custom availability for one-off meetings.
  • Generate slots of availability when any or all team members are available.
  • Automate and customize email notifications.
  • Collect preferred information during the attendee booking process.

Beta customers love how Zoom Scheduler saves time and consolidates meeting scheduling where it makes the most sense: in the middle of the communication platform they know and love.

“Zoom Scheduler offers an easy, no-effort integration with the rest of the Zoom platform,” said Gabe Moronta, Visla. “It has all the features, settings, and capability I need.”

Zoom Scheduler integrates with Zoom Calendar, which has become a resource for meetings both before and after. Zoom Calendar offers a sidebar view alongside the Zoom desktop client, so attendees can maximize their time by seeing if others have joined the meeting yet. After the meeting, shared files live in the Calendar invite for future reference.

Free and paid Zoom users can try out Zoom Scheduler for free anytime before July 19, 2023. On July 20, 2023, Scheduler will be available as an add-on for purchase for $5.99/month per user on Zoom’s website (add to any existing legacy Zoom plan or Zoom One plan), and will be included in the Zoom One Business Plus and Enterprise Plus plans.

About Zoom
Zoom is an all-in-one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

Zoom Public Relations
Lacretia Taylor
press@zoom.us

GlobeNewswire Distribution ID 8862086

Posted on

Curia Expands Cell Line Development Offering with CHOZN Platform

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies

ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS-/- cell line for production of therapeutic proteins and antibodies. Following the agreement, the CHOZN GS-/- cell line has been integrated into Curia’s cell line development workflow and is immediately available to Curia customers.

CHOZN® platform is a Chinese Hamster Ovary (CHO) mammalian cell expression system that allows for faster, simpler selection and scale-up of high-producing clones for production of biologics and therapeutic recombinant proteins. It includes high-performing CHO cell lines, paired media and feeds, optimized expression vectors and robust protocols. The glutamine synthetase GS knockout (GS-/-) cell line of the CHOZN platform is specially designed to help streamline selection, identification and scale-up of high-producing clones ideal for GMP manufacturing of recombinant protein drugs.

“We continue to strengthen our biologics development offerings from discovery through clinical manufacturing,” said Christopher Conway, President R&D, Curia. “The CHOZN GS-/- cell line platform adds a widely accepted and commercially viable cell line to our capabilities. Our integrated offering accelerates therapeutic protein and antibody production and offers seamless tech transfer for optimal flexibility.”

Curia’s protein and antibody development experts offer a track record of accelerating progress, with a timeline in as little as 12 months from cell line development to phase I drug substance, depending on the manufacturability of the candidates.

The addition of the CHOZN platform strengthens Curia’s offerings as a complement to its existing proprietary CHO cell line, providing customers with a highly versatile and broadly applicable solution.

About Curia
Curia is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 29 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8859845

Posted on

Curia Expande Oferta de Desenvolvimento de Linha Celular com a Plataforma CHOZN

Curia fecha contrato de licenciamento com a MilliporeSigma para apoiar a produção de proteínas e anticorpos

ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje a assinatura de um contrato de licenciamento com a MilliporeSigma, a divisão norte-americana de Ciências da Vida da Merck KGaA, Darmstadt, Alemanha, para que a Curia e seus clientes possam usar a linha de células CHOZN® GS-/- para a produção de proteínas e anticorpos terapêuticos. Com este acordo, a linha celular CHOZN GS-/- foi integrada ao fluxo de trabalho de desenvolvimento da linha celular da Curia que está imediatamente disponível para os clientes da Curia.

A plataforma CHOZN® é um sistema de expressão de células mamíferas de Ovário de Hamster Chinês (Chinese Hamster Ovary – CHO) que permite uma seleção e aumento de escala de forma mais rápida e simples de clones de alta produção para a geração de produtos biológicos e proteínas recombinantes terapêuticas. O sistema inclui linhas celulares CHO de alto desempenho, mídia e feeds emparelhados, vetores de expressão otimizados e protocolos robustos. A linha celular geneticamente modificada de glutamina sintetase GS (GS-/-) da plataforma CHOZN foi projetada especialmente para ajudar a agilizar a seleção, identificação e ampliação de clones de alta produção ideais para a fabricação de GMP de drogas de proteína recombinante.

“Continuamos a aprimorar nossas ofertas de desenvolvimento biológico desde a descoberta até a fabricação clínica”, disse Christopher Conway, presidente de P&D da Curia. “A plataforma de linhagem celular CHOZN GS-/- adiciona uma linhagem celular amplamente aceita e comercialmente viável às nossas capacidades. Nossa oferta integrada acelera a produção terapêutica de proteínas e anticorpos e oferece transferência de tecnologia perfeita para flexibilidade ideal.”

Os especialistas em desenvolvimento de proteínas e anticorpos da Curia tem um histórico de aceleração do progresso, com uma linha do tempo de apenas 12 meses, desde o desenvolvimento da linha celular até a substância medicamentosa da fase I, dependendo da capacidade de fabricação dos candidatos.

A adição da plataforma CHOZN fortalece as ofertas da Curia como um complemento à sua existente linha proprietária de células CHO, fornecendo aos clientes uma solução altamente versátil e amplamente aplicável.

Sobre a Curia
A Curia é uma organização líder em contratos de pesquisa, desenvolvimento e fabricação que fornece produtos e serviços de P&D por meio da fabricação comercial para clientes farmacêuticos e biofarmacêuticos. Os quase 4.000 funcionários da Curia em 29 locais nos EUA, Europa e Ásia ajudam seus clientes a avançar da curiosidade para a cura. Saiba mais em CuriaGlobal.com.

Contato da Curia:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8860042